Stefan Busemann

Stefan Busemann, PhD, currently serves as the Executive Vice President of Business Development at MS PHARMA since April 2020. Prior to this role, Busemann held significant positions including Vice President of Global Portfolio & Project Management at STADA and Global Head of Portfolio Management at Sandoz. Additional experience includes leadership roles at Sanofi, Actavis (now Allergan), ratiopharm, and co-founding 4SC AG, where Busemann also acted as Chief Financial Officer. Busemann's academic background includes a Diploma and PhD in Chemistry from the University of Wuerzburg, attained between 1990 and 1998.